Changes in serum apolipoprotein concentrations after L-thyroxine therapy in infants with congenital hypothyroidism

Metabolism: Clinical and Experimental

Volumn 48, Issue 11, 1999, Pages 1343-1345

  Asami, Tadashi ^a,b   Ciomartan, Tatiana ^a   Uchiyama, Makoto ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; LEVOTHYROXINE;

ARTICLE; CLINICAL ARTICLE; FEMALE; HORMONE ACTION; HUMAN; HYPOTHYROIDISM; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0032725196     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90140-3     Document Type: Article

References (28)

1. Ballantyne FC, Epenetos AA, Caslake M, et al: The composition of low-density lipoprotein subfractions in primary hypothyroidism and the effect of hormone-replacement therapy. Clin Sci 57:83-88, 1979
2. Abrams JJ, Grundy SM: Cholesterol metabolism in hypothyroidism and hyperthyroidism in man. J Lipid Res 22:323-328, 1981
3. Lithell H, Boberg J, Hellsing K, et al: Serum lipoprotein and apolipoprotein concentrations and tissue lipoprotein-lipase activity in overt and subclinical hypothyroidism: The effect of substitution therapy. Eur J Clin Invest 11:3-10, 1981
4. Raziel A, Rosenzweigh B, Borvinic V, et al: The influence of thyroid function on serum lipid profile. Atherosclerosis 41:321-326, 1982
5. Aviram M, Luboshitzky R, Brook J: Lipid and lipoprotein pattern in thyroid dysfunction and the effect of therapy. Clin Biochem 15:62-66, 1982
6. Wiseman SA, Powell JT, Humphries SE, et al: The magnitude of the hypercholesterolemia of hypothyroidism is associated with variation in the low density lipoprotein receptor gene. J Clin Endocrinol Metab 77:108-112, 1993
7. Spandrio S, Sleiman I, Scalvini T, et al: Lipoprotein (a) in thyroid dysfunction before and after treatment. Horm Metab Res 25:586-589, 1993
8. Asami T, Kikuchi T, Uchiyama M: Effects of L-thyroxine on serum lipid profiles in infants with congenital hypothyroidism. J Pediatr 127:812-814, 1995
9. Agdeppa D, Macaron C, Mallik T, et al: Plasma high density lipoprotein cholesterol in thyroid disease. J Clin Endocrinol Metab 49:726-729, 1979
10. Caron P, Calazel C, Parra HJ, et al: Decreased HDL cholesterol in subclinical hypothyroidism: The effect of L-thyroxine therapy. Clin Endocrinol (Oxf) 33:519-523, 1990
11. Gomo Z, Ascott MB: The association of serum thyroid stimulating hormone and serum lipids and lipoproteins in patients with suspected hypothyroidism. Cent Afr J Med 40:94-98, 1994
12. Murase T, Uchimura H: A selective decline of postheparin plasma hepatic triglyceride lipase in hypothyroid rats. Metabolism 29:797-801, 1980
13. Lacko AG, Marks AD, Rustenberg HL, et al: Serum cholesterol esterification in hyperthyroidism and hypothyroidism. Horm Metab Res 10:147-151, 1978
14. Gross G, Sykes M, Arellance R, et al: HDL clearance and receptor-mediated catabolism of LDL are reduced in hypothyroid rats. Atherosclerosis 66:269-275, 1987
15. Simonet WA, Ness GC: Transcriptional and posttranscriptional regulation of rat hepatic 3-hydroxy-3-methylglutaryl-coenzyme A reductase by thyroid hormones. J Biol Chem 263:12448-12453, 1988
16. Day R, Bebhard RL, Schwartz HL, et al: Time course of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and messenger ribonucleic acid, biliary lipid secretion, and hepatic cholesterol content in methimazole-treated hypothyroid and hypophysectomized rats after triiodothyronine administration: Possible linkage of cholesterol synthesis to biliary secretion. Endocrinology 125:459-468, 1989
17. Blangero J, Williams-Blangero S, Mahaney MC, et al: Effects of a major gene for apolipoprotein A-I concentration are thyroid hormone dependent in Mexican Americans. Arterioscler Thromb Vasc Biol 16:1177-1183, 1996
18. Ginsberg HN: Lipoprotein physiology and its relationship to atherogenesis. Endocrinol Metab Clin North Am 19:211-228, 1990
19. Muls E, Blaton V, Rossenneu M, et al: Serum lipids and apolipoproteins A-I, A-II, and B in hyperthyroidism before and after treatment. J Clin Endocrinol Metab 55:459-464, 1982
20. Muls E, Rosseneu M, Bury J, et al: Hyperthyroidism influences the distribution and apolipoprotein A composition of the high density lipoproteins in man. J Clin Endocrinol Metab 61:882-889, 1985
21. Muls E, Rosseneu M, Blaton V, et al: Serum lipids and apolipoproteins A-I, A-II, and B in primary hypothyroidism before and during treatment. Eur J Clin Invest 14:12-15, 1984
22. Wilcox HG, Frank RA, Heimberg M: Effects of thyroid status and fasting on hepatic metabolism of apolipoprotein A-I. J Lipid Res 32:395-405, 1991
23. Staels B, Van Tol A, Chan L, et al: Alterations in thyroid status modulate apolipoprotein, hepatic triglyceride lipase, and low density lipoprotein receptor in rats. Endocrinology 127:1144-1152, 1990
24. Fong BS, Greco AV, Angel A: Hypothyroidism reduces HDL binding to rat liver cells. Atherosclerosis 79:1-6, 1989
25. Apostolopoulos IJ, Marshall JF, Howlett GJ: Triiodothyronine increases rat apolipoprotein A-I synthesis and alters high-density lipoprotein composition in vivo. Eur J Biochem 194:147-154, 1990
26. Strobl W, Gorder NL, Lin-Lee YC, et al: Role of thyroid hormones in apolipoprotein A-I gene expression in rat liver. J Clin Invest 85:659-667, 1990
27. Strobl W, Chan L, Patsch W: Differential regulation of hepatic apolipoprotein A-I and A-II gene expression by thyroid hormone in rat liver. Atherosclerosis 97:161-170, 1992
28. Powell JT, Wiseman SA, Carter G, et al: Can thyroxine halt the progression of peripheral arterial disease? Eur J Vasc Surg 3:85-87, 1989